Immunoassay Market Size, Share, Trends, Industry Analysis Report: By Products, Technology, Specimen, Application, End Users, and Region

Description

List of Tables

The global immunoassay market size is expected to reach USD 50.95 billion by 2034, according to a new study by Polaris Market Research. The report "Immunoassay Market Size, Share, Trends, Industry Analysis Report: By Products (Reagents & Kits, Analyzers/Instruments, and Software & Services), Technology, Specimen, Application, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The immunoassay market growth is driven by increasing demand for precise diagnostic tools and advancements in technology. Immunoassays are primarily used to detect specific biomarkers such as proteins, lipids, and nucleic acids in biological samples and have become essential in clinical diagnostics, pharmaceutical research, and scientific investigations. The market is expanding rapidly, with key players leveraging innovations in assay platforms, multiplex testing, and automation to enhance diagnostic accuracy and efficiency. Furthermore, with the growing demand for faster, more accurate disease detection methods, the market is expected to witness significant growth opportunities during the forecast period.

The expanding healthcare infrastructure in emerging economies, which is improving access to advanced diagnostic solutions, is fueling the immunoassay market development. Additionally, the rising prevalence of chronic and infectious diseases, along with advancements in healthcare technology, is significantly boosting market demand. The increasing focus on preventive healthcare and the growing adoption of immunoassays in routine diagnostic practices are further creating immunoassay market opportunities.

The immunoassay market faces challenges, particularly due to stringent regulations associated with product development and validation. Regulatory bodies require extensive clinical testing and validation before the commercialization of products, which ultimately increases the development costs. Furthermore, the complexity of regulatory requirements varies by region, which complicates the entry of new products into international markets. These factors create barriers to innovation and increase the operational challenges for companies aiming to expand their market presence.

Immunoassay Market Report Highlights

In terms of products, the reagents & kits segment accounted for the largest immunoassay market share in 2024 due to their essential role in diagnostic testing, widespread usage in laboratories, and consistent demand for high-quality, accurate results.
Based on specimen type, the blood segment is expected to witness the fastest growth rate due to its high relevance in disease diagnosis, ease of collection, and ability to detect a wide range of biomarkers.
In 2024, North America accounted for the largest share of the global immunoassay market revenue, driven by advanced healthcare infrastructure, high demand for diagnostic tools, and significant investments in research and technology.
The Asia Pacific market is expected to witness the fastest growth during the forecast period due to rising healthcare awareness, expanding diagnostic capabilities, and growing demand for advanced medical technologies in the region.
A few of the global key market players are Abbott; BD; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; BIOMERIEUX; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc; Siemens Healthineers AG; QuidelOrtho Corporation; and Sysmex Corporation.

Polaris Market Research has segmented the immunoassay market report on the basis of products, technology, specimen, applications, end users, and region:

By Products Outlook (Revenue, USD Billion, 2021-2034)

Reagents & Kits
ELISA Reagents & Kits
Rapid Test Reagents & Kits
ELISPOT Reagents & Kits
Western Blot Reagents & Kits
Other Reagents & Kits
Analyzers/Instruments
Open Ended Systems
Closed Ended Systems
Software & Services

By Technology Outlook (Revenue, USD Billion, 2021-2034)

Radioimmunoassay (RIA)
Enzyme Immunoassays (EIA)
Chemiluminescence Immunoassays (CLIA)
Fluorescence Immunoassays (FIA)
Rapid Tests
Others

By Specimen Outlook (Revenue, USD Billion, 2021-2034)

Blood
Saliva
Urine
Others

By Application Outlook (Revenue, USD Billion, 2021-2034)

Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease Testing
Autoimmune Diseases
Others

By End Users Outlook (Revenue, USD Billion, 2021-2034)

Hospitals
Laboratories
Others

By Regional Outlook (Revenue, USD Billion, 2021-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM5069

Chapter 1. Introduction

1.1 Report Description
- 1.1.1 Objective of the Study
- 1.1.2 Market Scope
- 1.1.3 Assumptions
1.2 Stakeholders

Chapter 2. Research Methodology

2.1 Research Methodology
2.2 Research Scope and Assumptions
2.3 Information Procurement
- 2.3.1 Purchased Database
- 2.3.2 Internal Database
- 2.3.3 Secondary Sources
- 2.3.4 Third Party Perspective
- 2.3.5 Primary Research
2.4 Information Analysis
- 2.4.1 Data Analysis Models
2.5 Market Formulation and Data Visualization
2.6 Data Validation and Publishing (Secondary Sources)

Chapter 3. Executive Summary

Chapter 4. Market Insights

4.1 Immunoassay - Industry Snapshot
4.2 Immunoassay Market - Value Chain Analysis
- 4.2.1 Immunoassay Market Dynamics
- 4.2.2 Drivers and Opportunities
  - 4.2.2.1 Growing Prevalence of Chronic Diseases Globally
  - 4.2.2.2 Expanding Healthcare Infrastructure in Emerging Economies
- 4.2.3 Restraints and Challenges
  - 4.2.3.1 Stringent Regulation in Product Development and Validation
4.3 Immunoassay Market - Porter's Five Forces
- 4.3.1 Threat of Substitutes (Low to Moderate)
- 4.3.2 Threat of New Entrants (Moderate)
- 4.3.3 Bargaining Power of Buyers (Moderate to High)
- 4.3.4 Bargaining Power of Suppliers (Moderate)
- 4.3.5 Competitive Rivalry (High)
4.4 Immunoassay Market - PESTLE Analysis

Chapter 5. Immunoassay Market Assessment by Product

5.1 Introduction
5.2 Reagents & Kits
- 5.2.1 ELISA Reagents & Kits
- 5.2.2 Rapid Test Reagents & Kits
- 5.2.3 Western Blot Reagents & Kits
- 5.2.4 ELISPOT Reagents & Kits
- 5.2.5 Other Reagents & Kits
5.3 Analyzers/Instruments
- 5.3.1 Open Ended Systems
- 5.3.2 Closed Ended Systems
5.4 Software & Services

Chapter 6. Immunoassay Market Assessment by Technology

6.1 Introduction
6.2 Enzyme Immunoassays (EIA)
- 6.2.1 Chemiluminescence Immunoassays (CLIA)
- 6.2.2 Fluorescence Immunoassays (FIA)
6.3 Rapid Test
6.4 Radioimmunoassay (RIA)
6.5 Others

Chapter 7. Immunoassay Market Assessment by Specimen

7.1 Introduction
7.2 Blood
7.3 Urine
7.4 Saliva
7.5 Others

Chapter 8. Immunoassay Market Assessment by Application

8.1 Introduction
8.2 Infectious Disease Testing
8.3 Cardiology
8.4 Oncology
8.5 Endocrinology
8.6 Autoimmune Diseases
8.7 Therapeutic Drug Monitoring
8.8 Others

Chapter 9. Immunoassay Market Assessment by End Use

9.1 Introduction
9.2 Hospitals
9.3 Laboratories
9.4 Others

Chapter 10. Immunoassay Market Assessment by Region

10.1 Introduction
10.2 Immunoassay Market - North America
- 10.2.1 North America Immunoassay, Product
  - 10.2.1.1 North America Immunoassay, Reagents & Kits
  - 10.2.1.2 North America Immunoassay, Analyzers/Instruments
- 10.2.2 North America Immunoassay, Technology
  - 10.2.2.1 North America Immunoassay, Enzyme Immunoassays (EIA)
- 10.2.3 North America Immunoassay, Specimen
- 10.2.4 North America Immunoassay, Application
- 10.2.5 North America Immunoassay, End Use
- 10.2.6 Immunoassay Market - US
  - 10.2.6.1 US Immunoassay, Product
  - 10.2.6.1.1 US Immunoassay, Reagents & Kits
  - 10.2.6.1.2 US Immunoassay, Analyzers/Instruments
  - 10.2.6.2 US Immunoassay, Technology
  - 10.2.6.2.1 US Immunoassay, Enzyme Immunoassays (EIA)
  - 10.2.6.3 US Immunoassay, Specimen
  - 10.2.6.4 US Immunoassay, Application
  - 10.2.6.5 US Immunoassay, End Use
- 10.2.7 Immunoassay Market - Canada
  - 10.2.7.1 Canada Immunoassay, Product
  - 10.2.7.1.1 Canada Immunoassay, Reagents & Kits
  - 10.2.7.1.2 Canada Immunoassay, Analyzers/Instruments
  - 10.2.7.2 Canada Immunoassay, Technology
  - 10.2.7.2.1 Canada Immunoassay, Enzyme Immunoassays (EIA)
  - 10.2.7.3 Canada Immunoassay, Specimen
  - 10.2.7.4 Canada Immunoassay, Application
  - 10.2.7.5 Canada Immunoassay, End Use
10.3 Immunoassay Market - Europe
- 10.3.1 Europe Immunoassay, Product
  - 10.3.1.1 Europe Immunoassay, Reagents & Kits
  - 10.3.1.2 Europe Immunoassay, Analyzers/Instruments
- 10.3.2 Europe Immunoassay, Technology
  - 10.3.2.1 Europe Immunoassay Market, Enzyme Immunoassays (EIA)
- 10.3.3 Europe Immunoassay, Specimen
- 10.3.4 Europe Immunoassay, Application
- 10.3.5 Europe Immunoassay, End Use
- 10.3.6 Immunoassay Market - UK
  - 10.3.6.1 UK Immunoassay, Product
  - 10.3.6.1.1 UK Immunoassay, Reagents & Kits
  - 10.3.6.1.2 UK Immunoassay, Analyzers/Instruments
  - 10.3.6.2 UK Immunoassay, Technology
  - 10.3.6.2.1 UK Immunoassay, Enzyme Immunoassays (EIA)
  - 10.3.6.3 UK Immunoassay, Specimen
  - 10.3.6.4 UK Immunoassay, Application
  - 10.3.6.5 UK Immunoassay, End Use
- 10.3.7 Immunoassay Market - France
  - 10.3.7.1 France Immunoassay, Product
  - 10.3.7.1.1 France Immunoassay, Reagents & Kits
  - 10.3.7.1.2 France Immunoassay, Analyzers/Instruments
  - 10.3.7.2 France Immunoassay, Technology
  - 10.3.7.2.1 France Immunoassay, Enzyme Immunoassays (EIA)
  - 10.3.7.3 France Immunoassay, Specimen
  - 10.3.7.4 France Immunoassay, Application
  - 10.3.7.5 France Immunoassay, End Use
- 10.3.8 Immunoassay Market - Germany
  - 10.3.8.1 Germany Immunoassay, Product
  - 10.3.8.1.1 Germany Immunoassay, Reagents & Kits
  - 10.3.8.1.2 Germany Immunoassay, Analyzers/Instruments
  - 10.3.8.2 Germany Immunoassay, Technology
  - 10.3.8.2.1 Germany Immunoassay, Enzyme Immunoassays (EIA)
  - 10.3.8.3 Germany Immunoassay, Specimen
  - 10.3.8.4 Germany Immunoassay, Application
  - 10.3.8.5 Germany Immunoassay, End Use
- 10.3.9 Immunoassay Market - Italy
  - 10.3.9.1 Italy Immunoassay, Product
  - 10.3.9.1.1 Italy Immunoassay, Reagents & Kits
  - 10.3.9.1.2 Italy Immunoassay, Analyzers/Instruments
  - 10.3.9.2 Italy Immunoassay, Technology
  - 10.3.9.2.1 Italy Immunoassay, Enzyme Immunoassays (EIA)
  - 10.3.9.3 Italy Immunoassay, Specimen
  - 10.3.9.4 Italy Immunoassay, Application
  - 10.3.9.5 Italy Immunoassay, End Use
- 10.3.10 Immunoassay Market - Spain
  - 10.3.10.1 Spain Immunoassay, Product
  - 10.3.10.1.1 Spain Immunoassay, Reagents & Kits
  - 10.3.10.1.2 Spain Immunoassay, Analyzers/Instruments
  - 10.3.10.2 Spain Immunoassay, Technology
  - 10.3.10.2.1 Spain Immunoassay, Enzyme Immunoassays (EIA)
  - 10.3.10.3 Spain Immunoassay, Specimen
  - 10.3.10.4 Spain Immunoassay, Application
  - 10.3.10.5 Spain Immunoassay, End Use
- 10.3.11 Immunoassay Market - Netherlands
  - 10.3.11.1 Netherlands Immunoassay, Product
  - 10.3.11.1.1 Netherlands Immunoassay, Reagents & Kits
  - 10.3.11.1.2 Netherlands Immunoassay, Analyzers/Instruments
  - 10.3.11.2 Netherlands Immunoassay, Technology
  - 10.3.11.2.1 Netherlands Immunoassay, Enzyme Immunoassays (EIA)
  - 10.3.11.3 Netherlands Immunoassay, Specimen
  - 10.3.11.4 Netherlands Immunoassay, Application
  - 10.3.11.5 Netherlands Immunoassay, End Use
- 10.3.12 Immunoassay Market - Russia
  - 10.3.12.1 Russia Immunoassay, Product
  - 10.3.12.1.1 Russia Immunoassay, Reagents & Kits
  - 10.3.12.1.2 Russia Immunoassay, Analyzers/Instruments
  - 10.3.12.2 Russia Immunoassay, Technology
  - 10.3.12.2.1 Russia Immunoassay, Enzyme Immunoassays (EIA)
  - 10.3.12.3 Russia Immunoassay, Specimen
  - 10.3.12.4 Russia Immunoassay, Application
  - 10.3.12.5 Russia Immunoassay, End Use
- 10.3.13 Immunoassay Market - Rest of Europe
  - 10.3.13.1 Rest of Europe Immunoassay, Product
  - 10.3.13.1.1 Rest of Europe Immunoassay, Reagents & Kits
  - 10.3.13.1.2 Rest of Europe Immunoassay, Analyzers/Instruments
  - 10.3.13.2 Rest of Europe Immunoassay, Technology
  - 10.3.13.2.1 Rest of Europe Immunoassay, Enzyme Immunoassays (EIA)
  - 10.3.13.3 Rest of Europe Immunoassay, Specimen
  - 10.3.13.4 Rest of Europe Immunoassay, Application
  - 10.3.13.5 Rest of Europe Immunoassay, End Use
10.4 Immunoassay Market - Asia Pacific
- 10.4.1 Asia Pacific Immunoassay, Product
  - 10.4.1.1 Asia Pacific Immunoassay, Reagents & Kits
  - 10.4.1.2 Asia Pacific Immunoassay, Analyzers/Instruments
- 10.4.2 Asia Pacific Immunoassay, Technology
  - 10.4.2.1 Asia Pacific Immunoassay Market, Enzyme Immunoassays (EIA)
- 10.4.3 Asia Pacific Immunoassay, Specimen
- 10.4.4 Asia Pacific Immunoassay, Application
- 10.4.5 Asia Pacific Immunoassay, End Use
- 10.4.6 Immunoassay Market - China
  - 10.4.6.1 China Immunoassay, Product
  - 10.4.6.1.1 China Immunoassay, Reagents & Kits
  - 10.4.6.1.2 China Immunoassay, Analyzers/Instruments
  - 10.4.6.2 China Immunoassay, Technology
  - 10.4.6.2.1 China Immunoassay, Enzyme Immunoassays (EIA)
  - 10.4.6.3 China Immunoassay, Specimen
  - 10.4.6.4 China Immunoassay, Application
  - 10.4.6.5 China Immunoassay, End Use
- 10.4.7 Immunoassay Market - Japan
  - 10.4.7.1 Japan Immunoassay, Product
  - 10.4.7.1.1 Japan Immunoassay, Reagents & Kits
  - 10.4.7.1.2 Japan Immunoassay, Analyzers/Instruments
  - 10.4.7.2 Japan Immunoassay, Technology
  - 10.4.7.2.1 Japan Immunoassay, Enzyme Immunoassays (EIA)
  - 10.4.7.3 Japan Immunoassay, Specimen
  - 10.4.7.4 Japan Immunoassay, Application
  - 10.4.7.5 Japan Immunoassay, End Use
- 10.4.8 Immunoassay Market - South Korea
  - 10.4.8.1 South Korea Immunoassay, Product
  - 10.4.8.1.1 South Korea Immunoassay, Reagents & Kits
  - 10.4.8.1.2 South Korea Immunoassay, Analyzers/Instruments
  - 10.4.8.2 South Korea Immunoassay, Technology
  - 10.4.8.2.1 South Korea Immunoassay, Enzyme Immunoassays (EIA)
  - 10.4.8.3 South Korea Immunoassay, Specimen
  - 10.4.8.4 South Korea Immunoassay, Application
  - 10.4.8.5 South Korea Immunoassay, End Use
- 10.4.9 Immunoassay Market - India
  - 10.4.9.1 India Immunoassay, Product
  - 10.4.9.1.1 India Immunoassay, Reagents & Kits
  - 10.4.9.1.2 India Immunoassay, Analyzers/Instruments
  - 10.4.9.2 India Immunoassay, Technology
  - 10.4.9.2.1 India Immunoassay, Enzyme Immunoassays (EIA)
  - 10.4.9.3 India Immunoassay, Specimen
  - 10.4.9.4 India Immunoassay, Application
  - 10.4.9.5 India Immunoassay, End Use
- 10.4.10 Immunoassay Market - Malaysia
  - 10.4.10.1 Malaysia Immunoassay, Product
  - 10.4.10.1.1 Malaysia Immunoassay, Reagents & Kits
  - 10.4.10.1.2 Malaysia Immunoassay, Analyzers/Instruments
  - 10.4.10.2 Malaysia Immunoassay, Technology
  - 10.4.10.2.1 Malaysia Immunoassay, Enzyme Immunoassays (EIA)
  - 10.4.10.3 Malaysia Immunoassay, Specimen
  - 10.4.10.4 Malaysia Immunoassay, Application
  - 10.4.10.5 Malaysia Immunoassay, End Use
- 10.4.11 Immunoassay Market - Australia
  - 10.4.11.1 Australia Immunoassay, Product
  - 10.4.11.1.1 Australia Immunoassay, Reagents & Kits
  - 10.4.11.1.2 Australia Immunoassay, Analyzers/Instruments
  - 10.4.11.2 Australia Immunoassay, Technology
  - 10.4.11.2.1 Australia Immunoassay, Enzyme Immunoassays (EIA)
  - 10.4.11.3 Australia Immunoassay, Specimen
  - 10.4.11.4 Australia Immunoassay, Application
  - 10.4.11.5 Australia Immunoassay, End Use
- 10.4.12 Immunoassay Market - Indonesia
  - 10.4.12.1 Indonesia Immunoassay, Product
  - 10.4.12.1.1 Indonesia Immunoassay, Reagents & Kits
  - 10.4.12.1.2 Indonesia Immunoassay, Analyzers/Instruments
  - 10.4.12.2 Indonesia Immunoassay, Technology
  - 10.4.12.2.1 Indonesia Immunoassay, Enzyme Immunoassays (EIA)
  - 10.4.12.3 Indonesia Immunoassay, Specimen
  - 10.4.12.4 Indonesia Immunoassay, Application
  - 10.4.12.5 Indonesia Immunoassay, End Use
- 10.4.13 Immunoassay Market - Rest of Asia Pacific
  - 10.4.13.1 Rest of Asia Pacific Immunoassay, Product
  - 10.4.13.1.1 Rest of Asia Pacific Immunoassay, Reagents & Kits
  - 10.4.13.1.2 Rest of Asia Pacific Immunoassay, Analyzers/Instruments
  - 10.4.13.2 Rest of Asia Pacific Immunoassay, Technology
  - 10.4.13.2.1 Rest of Asia Pacific Immunoassay, Enzyme Immunoassays (EIA)
  - 10.4.13.3 Rest of Asia Pacific Immunoassay, Specimen
  - 10.4.13.4 Rest of Asia Pacific Immunoassay, Application
  - 10.4.13.5 Rest of Asia Pacific Immunoassay, End Use
10.5 Immunoassay Market - Latin America
- 10.5.1 Latin America Immunoassay, Product
  - 10.5.1.1 Latin America Immunoassay, Reagents & Kits
  - 10.5.1.2 Latin America Immunoassay, Analyzers/Instruments
- 10.5.2 Latin America Immunoassay, Technology
  - 10.5.2.1 Latin America Immunoassay Market, Enzyme Immunoassays (EIA)
- 10.5.3 Latin America Immunoassay, Specimen
- 10.5.4 Latin America Immunoassay, Application
- 10.5.5 Latin America Immunoassay, End Use
- 10.5.6 Immunoassay Market - Brazil
  - 10.5.6.1 Brazil Immunoassay, Product
  - 10.5.6.1.1 Brazil Immunoassay, Reagents & Kits
  - 10.5.6.1.2 Brazil Immunoassay, Analyzers/Instruments
  - 10.5.6.2 Brazil Immunoassay, Technology
  - 10.5.6.2.1 Brazil Immunoassay, Enzyme Immunoassays (EIA)
  - 10.5.6.3 Brazil Immunoassay, Specimen
  - 10.5.6.4 Brazil Immunoassay, Application
  - 10.5.6.5 Brazil Immunoassay, End Use
- 10.5.7 Immunoassay Market - Mexico
  - 10.5.7.1 Mexico Immunoassay, Product
  - 10.5.7.1.1 Mexico Immunoassay, Reagents & Kits
  - 10.5.7.1.2 Mexico Immunoassay, Analyzers/Instruments
  - 10.5.7.2 Mexico Immunoassay, Technology
  - 10.5.7.2.1 Mexico Immunoassay, Enzyme Immunoassays (EIA)
  - 10.5.7.3 Mexico Immunoassay, Specimen
  - 10.5.7.4 Mexico Immunoassay, Application
  - 10.5.7.5 Mexico Immunoassay, End Use
- 10.5.8 Immunoassay Market - Argentina
  - 10.5.8.1 Argentina Immunoassay, Product
  - 10.5.8.1.1 Argentina Immunoassay, Reagents & Kits
  - 10.5.8.1.2 Argentina Immunoassay, Analyzers/Instruments
  - 10.5.8.2 Argentina Immunoassay, Technology
  - 10.5.8.2.1 Argentina Immunoassay, Enzyme Immunoassays (EIA)
  - 10.5.8.3 Argentina Immunoassay, Specimen
  - 10.5.8.4 Argentina Immunoassay, Application
  - 10.5.8.5 Argentina Immunoassay, End Use
- 10.5.9 Immunoassay Market - Rest of Latin America
  - 10.5.9.1 Rest of Latin America Immunoassay, Product
  - 10.5.9.1.1 Rest of Latin America Immunoassay, Reagents & Kits
  - 10.5.9.1.2 Rest of Latin America Immunoassay, Analyzers/Instruments
  - 10.5.9.2 Rest of Latin America Immunoassay, Technology
  - 10.5.9.2.1 Rest of Latin America Immunoassay, Enzyme Immunoassays (EIA)
  - 10.5.9.3 Rest of Latin America Immunoassay, Specimen
  - 10.5.9.4 Rest of Latin America Immunoassay, Application
  - 10.5.9.5 Rest of Latin America Immunoassay, End Use
10.6 Immunoassay Market - Middle East and Africa
- 10.6.1 Middle East and Africa Immunoassay, Product
  - 10.6.1.1 Middle East and Africa Immunoassay, Reagents & Kits
  - 10.6.1.2 Middle East and Africa Immunoassay, Analyzers/Instruments
- 10.6.2 Middle East and Africa Immunoassay, Technology
  - 10.6.2.1 Middle East and Africa Immunoassay Market, Enzyme Immunoassays (EIA)
- 10.6.3 Middle East and Africa Immunoassay, Specimen
- 10.6.4 Middle East and Africa Immunoassay, Application
- 10.6.5 Middle East and Africa Immunoassay, End Use
- 10.6.6 Immunoassay Market - UAE
  - 10.6.6.1 UAE Immunoassay, Product
  - 10.6.6.1.1 UAE Immunoassay, Reagents & Kits
  - 10.6.6.1.2 UAE Immunoassay, Analyzers/Instruments
  - 10.6.6.2 UAE Immunoassay, Technology
  - 10.6.6.2.1 UAE Immunoassay, Enzyme Immunoassays (EIA)
  - 10.6.6.3 UAE Immunoassay, Specimen
  - 10.6.6.4 UAE Immunoassay, Application
  - 10.6.6.5 UAE Immunoassay, End Use
- 10.6.7 Immunoassay Market - Israel
  - 10.6.7.1 Israel Immunoassay, Product
  - 10.6.7.1.1 Israel Immunoassay, Reagents & Kits
  - 10.6.7.1.2 Israel Immunoassay, Analyzers/Instruments
  - 10.6.7.2 Israel Immunoassay, Technology
  - 10.6.7.2.1 Israel Immunoassay, Enzyme Immunoassays (EIA)
  - 10.6.7.3 Israel Immunoassay, Specimen
  - 10.6.7.4 Israel Immunoassay, Application
  - 10.6.7.5 Israel Immunoassay, End Use
- 10.6.8 Immunoassay Market - Saudi Arabia
  - 10.6.8.1 Saudi Arabia Immunoassay, Product
  - 10.6.8.1.1 Saudi Arabia Immunoassay, Reagents & Kits
  - 10.6.8.1.2 Saudi Arabia Immunoassay, Analyzers/Instruments
  - 10.6.8.2 Saudi Arabia Immunoassay, Technology
  - 10.6.8.2.1 Saudi Arabia Immunoassay, Enzyme Immunoassays (EIA)
  - 10.6.8.3 Saudi Arabia Immunoassay, Specimen
  - 10.6.8.4 Saudi Arabia Immunoassay, Application
  - 10.6.8.5 Saudi Arabia Immunoassay, End Use
- 10.6.9 Immunoassay Market - South Africa
  - 10.6.9.1 South Africa Immunoassay, Product
  - 10.6.9.1.1 South Africa Immunoassay, Reagents & Kits
  - 10.6.9.1.2 South Africa Immunoassay, Analyzers/Instruments
  - 10.6.9.2 South Africa Immunoassay, Technology
  - 10.6.9.2.1 South Africa Immunoassay, Enzyme Immunoassays (EIA)
  - 10.6.9.3 South Africa Immunoassay, Specimen
  - 10.6.9.4 South Africa Immunoassay, Application
  - 10.6.9.5 South Africa Immunoassay, End Use
- 10.6.10 Immunoassay Market - Rest of Middle East & Africa
  - 10.6.10.1 Rest of Middle East & Africa Immunoassay, Product
  - 10.6.10.1.1 Rest of Middle East & Africa Immunoassay, Reagents & Kits
  - 10.6.10.1.2 Rest of Middle East & Africa Immunoassay, Analyzers/Instruments
  - 10.6.10.2 Rest of Middle East & Africa Immunoassay, Technology
  - 10.6.10.2.1 Rest of Middle East & Africa Immunoassay, Enzyme Immunoassays (EIA)
  - 10.6.10.3 Rest of Middle East & Africa Immunoassay, Specimen
  - 10.6.10.4 Rest of Middle East & Africa Immunoassay, Application
  - 10.6.10.5 Rest of Middle East & Africa Immunoassay, End Use

Chapter 11. Competitive Landscape

11.1 Key Market Players: Categorization
11.2 Strategy Framework
11.3 Vendor Landscape
11.4 Strategies Categorization
- 11.4.1 Product Launch/ Product Development
- 11.4.2 Partnership/Acquisition/Collaboration

Chapter 12. Company Profiles

12.1 Abbott
- 12.1.1 Business Overview
- 12.1.2 Financial Snapshot
  - 12.1.2.1 Net Sales by Market Segment
- 12.1.3 Products and Services
12.2 BD
- 12.2.1 Business Overview
- 12.2.2 Financial Snapshot
  - 12.2.2.1 Revenue by Market Segment
  - 12.2.2.2 Revenue by Region
- 12.2.3 Products and Services
12.3 Beckman Coulter, Inc.
- 12.3.1 Business Overview
- 12.3.2 Products and Services
- 12.3.3 Recent Developments
12.4 Bio-Rad Laboratories, Inc.
- 12.4.1 Business Overview
- 12.4.2 Financial Snapshot
  - 12.4.2.1 Net Sales by Segment
  - 12.4.2.2 Net Sales by Region
- 12.4.3 Products and Services
- 12.4.4 Recent Developments
12.5 BIOMERIEUX
- 12.5.1 Business Overview
- 12.5.2 Financial Snapshot
  - 12.5.2.1 Revenue by Segment
  - 12.5.2.2 Revenue by Region
- 12.5.3 Products and Services
- 12.5.4 Recent Developments
12.6 F. Hoffmann-La Roche Ltd
- 12.6.1 Business Overview
- 12.6.2 Financial Snapshot
  - 12.6.2.1 Sales by Market Segment
  - 12.6.2.2 Sales by Region
- 12.6.3 Products and Services
- 12.6.4 Recent Developments
12.7 Thermo Fisher Scientific Inc.
- 12.7.1 Business Overview
- 12.7.2 Financial Snapshot
  - 12.7.2.1 Revenue by Segment
  - 12.7.2.2 Revenue by Region
- 12.7.3 Products and Services
- 12.7.4 Recent Developments
12.8 Siemens Healthineers AG
- 12.8.1 Business Overview
- 12.8.2 Financial Snapshot
  - 12.8.2.1 Revenue by Segment
  - 12.8.2.2 Revenue by Region
- 12.8.3 Products and Services
- 12.8.4 Recent Developments
12.9 QuidelOrtho Corporation
- 12.9.1 Business Overview
- 12.9.2 Financial Snapshot
  - 12.9.2.1 Revenue by Segment
  - 12.9.2.2 Revenue by Region
- 12.9.3 Products and Services
12.10 Sysmex Corporation
- 12.10.1 Business Overview
- 12.10.2 Financial Snapshot
  - 12.10.2.1 Net Sales by Segment
  - 12.10.2.2 Net Sales by Region
- 12.10.3 Products and Services